Inmolecule Nanotech (XPAR:MLINA) EV-to-EBIT: (As of Aug. 23, 2026)

Name: Inmolecule Nanotech SA (MLINA) — Historical Annual & Quarterly Data
Creator: GuruFocus
License: https://www.gurufocus.com/terms-of-service.php

Author:

Vera Yuan

Director of Data and Quant Analytics at GuruFocus

Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.

View Profile →

Reviewed by:

Charlie Tian

Founder & CEO of GuruFocus

Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

View Profile →

Inmolecule Nanotech SA XPAR:MLINA

Start Your Free 7-Day GuruFocus Premium Trial

Unlock 30-Y financials, GF Score, and 150+ pro screeners →

What is Inmolecule Nanotech EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Inmolecule Nanotech's Enterprise Value is €32.52 Mil. Inmolecule Nanotech does not have enough years/quarters to calculate its EBIT for the trailing twelve months (TTM) ended in Dec. 2024. Therefore, GuruFocus does not calculate Inmolecule Nanotech's EV-to-EBIT at this moment.

The historical rank and industry rank for Inmolecule Nanotech's EV-to-EBIT or its related term are showing as below:

XPAR:MLINA' s EV-to-EBIT Range Over the Past 10 Years
Min: -149.86 Med: 0 Max: 0
Current: -149.86

XPAR:MLINA's EV-to-EBIT is ranked worse than
100% of 376 companies
in the Biotechnology industry
Industry Median: 16.16 vs XPAR:MLINA: -149.86

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Inmolecule Nanotech's Enterprise Value for the quarter that ended in Dec. 2024 was €0.00 Mil. Inmolecule Nanotech does not have enough years/quarters to calculate its EBIT for the trailing twelve months (TTM) ended in Dec. 2024. Therefore, GuruFocus does not calculate Inmolecule Nanotech's Earnings Yield (Joel Greenblatt) % at this moment.

Try GuruFocus Premium free for 7 days

Unlock GF Score, GF Value, 30-Y financials, and pro screeners.

Get Started →

Inmolecule Nanotech (XPAR:MLINA) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Inmolecule Nanotech's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2024 )	=	EBIT	/	Enterprise Value (Q: Dec. 2024 )
	=		/	0
	=	%

Inmolecule Nanotech EV-to-EBIT Related Terms

Inmolecule Nanotech EV-to-EBIT Historical Data

* Premium members only.

The historical data trend for Inmolecule Nanotech's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Inmolecule Nanotech EV-to-EBIT Chart

Inmolecule Nanotech Annual Data

Trend

Dec23

Dec24

EV-to-EBIT

0.00

Inmolecule Nanotech Semi-Annual Data
	Dec23	Dec24
EV-to-EBIT	0.00	0.00

XPAR:MLINA vs VRTX, REGN, RVMD: EV-to-EBIT Comparison

For the Biotechnology subindustry, Inmolecule Nanotech's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.